Half-Dose TNKase Holds Up for Pharmaco-Invasive Reperfusion in STEMI

(MedPage Today) -- When timely angioplasty is unavailable to older ST-segment elevation myocardial infarction (STEMI) patients, a modified pharmaco-invasive reperfusion strategy could be reasonable, according to the STREAM-2 trial. Half-dose tenecteplase...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news